247 related articles for article (PubMed ID: 25093377)
1. Human immunodeficiency virus-associated multicentric Castleman disease refractory to antiretroviral therapy: clinical features, treatment and outcome.
Alzahrani M; Hull MC; Sherlock C; Griswold D; Leger CS; Leitch HA
Leuk Lymphoma; 2015 May; 56(5):1246-51. PubMed ID: 25093377
[TBL] [Abstract][Full Text] [Related]
2. Human Herpesvirus Type 8-positive Multicentric Castleman Disease.
Melikyan AL; Egorova EK; Julhakyan HL; Kovrigina AL; Savchenko VG
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S159-65. PubMed ID: 27133959
[TBL] [Abstract][Full Text] [Related]
3. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
Simonelli C; Tedeschi R; Gloghini A; Talamini R; Bortolin MT; Berretta M; Spina M; Morassut S; Vaccher E; De Paoli P; Carbone A; Tirelli U
J Med Virol; 2009 May; 81(5):888-96. PubMed ID: 19319955
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and survival for HIV-associated multicentric Castleman disease in Malawi.
Gopal S; Liomba NG; Montgomery ND; Moses A; Kaimila B; Nyasosela R; Chikasema M; Dhungel BM; Kampani C; Sanders MK; Krysiak R; Dittmer DP; Fedoriw Y
J Int AIDS Soc; 2015; 18(1):20122. PubMed ID: 26242311
[TBL] [Abstract][Full Text] [Related]
5. Human Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature.
Foster WR; Bischin A; Dorer R; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):311-21. PubMed ID: 27234438
[TBL] [Abstract][Full Text] [Related]
6. [A case of HIV-1 and HHV-8-associated Castleman disease with a relapsing high fever and lymphoadenopathy].
Minami R; Yamamoto M
Kansenshogaku Zasshi; 2006 Jul; 80(4):423-7. PubMed ID: 16922487
[TBL] [Abstract][Full Text] [Related]
7. EBV+ HHV-8+ Multicentric Castleman Disease With Plasmablastic Aggregates in an HIV+ Man: An Evolving Clinicopathologic Entity.
Shivane A; Pearce A; Khatib N; Smith MEF
Int J Surg Pathol; 2018 Jun; 26(4):338-341. PubMed ID: 29198143
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune thrombotic thrombocytopenic purpura associated with HHV8-related Multicentric Castleman disease.
London J; Boutboul D; Agbalika F; Coppo P; Veyradier A; Gérard L; Oksenhendler E; Azoulay E; Galicier L
Br J Haematol; 2017 Aug; 178(3):486-488. PubMed ID: 27221364
[No Abstract] [Full Text] [Related]
9. Human herpesvirus 8+ polyclonal IgMλ B-cell lymphocytosis mimicking plasmablastic leukemia/lymphoma in HIV-infected patients.
Oksenhendler E; Boutboul D; Beldjord K; Meignin V; de Labarthe A; Fieschi C; Dossier A; Agbalika F; Parravicini C; Tosato G; Gérard L; Galicier L
Eur J Haematol; 2013 Dec; 91(6):497-503. PubMed ID: 23992152
[TBL] [Abstract][Full Text] [Related]
10. Human herpesvirus 8-associated multicentric Castleman disease in a patient with advanced HIV infection: A case report.
Guayboon T; Chinthammitr Y; Sukpanichnant S; Horthongkham N; Angkasekwinai N
Medicine (Baltimore); 2021 Dec; 100(49):e28077. PubMed ID: 34889256
[TBL] [Abstract][Full Text] [Related]
11. Short Communication: CD4 Count and HIV RNA Trends for HIV-Associated Lymphoproliferative Disorders in Malawi.
Kaimila B; van der Gronde T; Kasonkanji E; Fox P; Chikasema M; Tewete B; Gopal S
AIDS Res Hum Retroviruses; 2017 Oct; 33(10):1045-1047. PubMed ID: 28548539
[TBL] [Abstract][Full Text] [Related]
12. Immune reconstitution inflammatory syndrome, human herpesvirus 8 viremia, and HIV-associated multicentric Castleman disease.
Siegel MO; Ghafouri S; Ajmera R; Simon GL
Int J Infect Dis; 2016 Jul; 48():49-51. PubMed ID: 27173076
[TBL] [Abstract][Full Text] [Related]
13. Human herpesvirus 8-related Castleman disease in the absence of HIV infection.
Dossier A; Meignin V; Fieschi C; Boutboul D; Oksenhendler E; Galicier L
Clin Infect Dis; 2013 Mar; 56(6):833-42. PubMed ID: 23223599
[TBL] [Abstract][Full Text] [Related]
14. Human Herpesvirus-8 Negative Multicentric Castleman Disease in a Patient with Human Immunodeficiency Virus Treated with Highly Active Antiretroviral Therapy and Chemotherapy.
Freeman SC; Baskaran J; Gbadamosi-Akindele M
Cureus; 2019 Aug; 11(8):e5530. PubMed ID: 31523587
[TBL] [Abstract][Full Text] [Related]
15. The full spectrum of Castleman disease: 273 patients studied over 20 years.
Oksenhendler E; Boutboul D; Fajgenbaum D; Mirouse A; Fieschi C; Malphettes M; Vercellino L; Meignin V; Gérard L; Galicier L
Br J Haematol; 2018 Jan; 180(2):206-216. PubMed ID: 29143319
[TBL] [Abstract][Full Text] [Related]
16. Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease.
Stebbing J; Adams C; Sanitt A; Mletzko S; Nelson M; Gazzard B; Newsom-Davis T; Bower M
Blood; 2011 Jul; 118(2):271-5. PubMed ID: 21511959
[TBL] [Abstract][Full Text] [Related]
17. HIV-associated multicentric Castleman disease.
Reddy D; Mitsuyasu R
Curr Opin Oncol; 2011 Sep; 23(5):475-81. PubMed ID: 21760504
[TBL] [Abstract][Full Text] [Related]
18. Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment.
Casper C; Nichols WG; Huang ML; Corey L; Wald A
Blood; 2004 Mar; 103(5):1632-4. PubMed ID: 14615380
[TBL] [Abstract][Full Text] [Related]
19. Treatment of multicentric Castleman’s disease in HIV-1 infected and uninfected patients: a systematic review.
Rokx C; Rijnders BJ; van Laar JA
Neth J Med; 2015 Jun; 73(5):202-10. PubMed ID: 26087799
[TBL] [Abstract][Full Text] [Related]
20. Characterization of immunologic and virological parameters in HIV-infected patients with primary effusion lymphoma during antiblastic therapy and highly active antiretroviral therapy.
Simonelli C; Tedeschi R; Gloghini A; Bortolin MT; Spina M; Bidoli E; Cinelli R; De Paoli P; Carbone A; Tirelli U
Clin Infect Dis; 2005 Apr; 40(7):1022-7. PubMed ID: 15824995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
